Join
Live feed
·
INSIDERFilingvia Quantisnow
Ventyx Biosciences Inc. logo

CHIEF SCIENTIFIC OFFICER Nuss John sold $49,841 worth of shares (21,119 units at $2.36), decreasing direct ownership by 4% to 464,582 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VTYX· Ventyx Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTYX (Ventyx Biosciences Inc.) and more on Quantisnow.